{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T23:59:24Z","timestamp":1780876764462,"version":"3.54.1"},"posted":{"date-parts":[[2026,5,8]]},"group-title":"In Review","reference-count":60,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,4,22]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  The mechanisms of resistance to Bruton tyrosine kinase inhibitors (BTKi) in MCL are not well understood. We found that cyclin-dependent kinase 5 (CDK5), a serine\/threonine kinase, was upregulated in ibrutinib-resistant MCL cell lines and in primary MCL cells obtained from patients who progressed on BTKi. Furthermore, primary MCL cells upregulated CDK5 in BAFF\/CD40L stromal conditions, and\n                  <italic>CDK5<\/italic>\n                  mRNA overexpression in primary MCL tumors was associated with inferior outcomes. Genetic and pharmacologic (GFB-12811) manipulation of CDK5 in MCL cell lines revealed that CDK5 contributed to proliferation and ibrutinib resistance\n                  <italic>in vitro<\/italic>\n                  , while engineered expression of CDK5 in JeKo-1 cells shortened survival in a murine xenograft model. CDK5 was upregulated by B-cell receptor and BAFF signaling and complexed with BTK. Mass spectrometry analysis of CDK5-manipulated cells revealed that cell cycle and metabolism-related pathways were most affected by CDK5; 29 kinases were differentially active, and Src kinase activity correlated with CDK5 expression. CDK5 complexed with IRE1\u03b1 and Xbp1, promoted IRE1\u03b1 phosphorylation and increased Xbp1 levels thus facilitating unfolded protein response. Meanwhile, Xbp1 knockdown resensitized MCL cells to ibrutinib. Collectively, CDK5 promotes BTKi resistance via modulation of the XBP1\/IRE1\u03b1 axis of the UPR pathway and represents a potential therapeutic target in MCL.\n                <\/p>","DOI":"10.21203\/rs.3.rs-9500406\/v1","type":"posted-content","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T16:24:28Z","timestamp":1778257468000},"source":"Crossref","is-referenced-by-count":0,"title":["Cyclin-Dependent Kinase 5 Contributes to Bruton\u2019s Tyrosine Kinase Inhibitor Resistance via the IRE1\u03b1\/XBP1 Axis in Mantle Cell Lymphoma"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4461-0970","authenticated-orcid":false,"given":"Alexey","family":"Danilov","sequence":"first","affiliation":[{"name":"City of Hope"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5474-8598","authenticated-orcid":false,"given":"Sonia","family":"Rodriguez-Rodriguez","sequence":"additional","affiliation":[{"name":"City of Hope"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Vuong","sequence":"additional","affiliation":[{"name":"City of Hope"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijia","family":"Yan","sequence":"additional","affiliation":[{"name":"City of Hope"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Chen","sequence":"additional","affiliation":[{"name":"City of Hope"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Roleder","sequence":"additional","affiliation":[{"name":"City of Hope"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiana","family":"huynh","sequence":"additional","affiliation":[{"name":"City of Hope"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vi","family":"Lam","sequence":"additional","affiliation":[{"name":"Oregon Health and Science University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Shen","sequence":"additional","affiliation":[{"name":"City of Hope"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3099-6665","authenticated-orcid":false,"given":"Jibin","family":"Zhang","sequence":"additional","affiliation":[{"name":"City of Hope National Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhou","family":"Ge","sequence":"additional","affiliation":[{"name":"Oregon State University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8212-3586","authenticated-orcid":false,"given":"Lucy","family":"Ghoda","sequence":"additional","affiliation":[{"name":"Department of Hematology and HCT, City of Hope"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Pak","sequence":"additional","affiliation":[{"name":"City of Hope"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9501-6990","authenticated-orcid":false,"given":"Vu","family":"Ngo","sequence":"additional","affiliation":[{"name":"Beckman Research Institute, City of Hope"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7917-5713","authenticated-orcid":false,"given":"Geoffrey","family":"Shouse","sequence":"additional","affiliation":[{"name":"City of Hope National Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tycel","family":"Phillips","sequence":"additional","affiliation":[{"name":"City of Hope"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[{"name":"Columbia University Irvine Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ajh.27202","article-title":"The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes","volume":"99","author":"Cerhan JR","year":"2024","unstructured":"Cerhan JR, Maurer MJ, Link BK, Feldman AL, Habermann TM, Jaye DL, et al. The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. Am J Hematol 2024; 99(3): 408\u2013421.","journal-title":"Am J Hematol"},{"issue":"45","key":"ref2","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.1073\/pnas.1314608110","article-title":"Landscape of somatic mutations and clonal evolution in mantle cell lymphoma","volume":"110","author":"Bea S","year":"2013","unstructured":"Bea S, Valdes-Mas R, Navarro A, Salaverria I, Martin-Garcia D, Jares P, et al. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc Natl Acad Sci U S A 2013; 110(45): 18250\u201318255.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"107615","DOI":"10.1016\/j.leukres.2024.107615","article-title":"Advances in the treatment of mantle cell lymphoma with BTK inhibitors","volume":"147","author":"Shen J","year":"2024","unstructured":"Shen J, Li J, Yang R, Wu S, Mu Z, Ding S, et al. Advances in the treatment of mantle cell lymphoma with BTK inhibitors. Leuk Res 2024; 147: 107615.","journal-title":"Leuk Res"},{"issue":"17","key":"ref4","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1182\/blood-2017-10-810044","article-title":"Single-agent ibrutinib in treatment-naive and relapsed\/refractory chronic lymphocytic leukemia: a 5-year experience","volume":"131","author":"O'Brien S","year":"2018","unstructured":"O'Brien S, Furman RR, Coutre S, Flinn IW, Burger JA, Blum K, et al. Single-agent ibrutinib in treatment-naive and relapsed\/refractory chronic lymphocytic leukemia: a 5-year experience. Blood 2018; 131(17): 1910\u20131919.","journal-title":"Blood"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/bjh.17184","article-title":"Incorporating acalabrutinib, a selective next-generation Bruton tyrosine kinase inhibitor, into clinical practice for the treatment of haematological malignancies","volume":"193","author":"Danilov AV","year":"2021","unstructured":"Danilov AV, Persky DO. Incorporating acalabrutinib, a selective next-generation Bruton tyrosine kinase inhibitor, into clinical practice for the treatment of haematological malignancies. Br J Haematol 2021; 193(1): 15\u201325.","journal-title":"Br J Haematol"},{"issue":"26","key":"ref6","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMra2202672","article-title":"Mantle-Cell Lymphoma","volume":"386","author":"Armitage JO","year":"2022","unstructured":"Armitage JO, Longo DL. Mantle-Cell Lymphoma. N Engl J Med 2022; 386(26): 2495\u20132506.","journal-title":"N Engl J Med"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/bjh.15108","article-title":"Ibrutinib resistance in mantle cell lymphoma: clinical, molecular and treatment aspects","volume":"181","author":"Hershkovitz-Rokah O","year":"2018","unstructured":"Hershkovitz-Rokah O, Pulver D, Lenz G, Shpilberg O. Ibrutinib resistance in mantle cell lymphoma: clinical, molecular and treatment aspects. Br J Haematol 2018; 181(3): 306\u2013319.","journal-title":"Br J Haematol"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nm.3435","article-title":"Pharmacological and genomic profiling identifies NF-kappaB-targeted treatment strategies for mantle cell lymphoma","volume":"20","author":"Rahal R","year":"2014","unstructured":"Rahal R, Frick M, Romero R, Korn JM, Kridel R, Chan FC, et al. Pharmacological and genomic profiling identifies NF-kappaB-targeted treatment strategies for mantle cell lymphoma. Nat Med 2014; 20(1): 87\u201392.","journal-title":"Nat Med"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/2159-8290.CD-14-0098","article-title":"Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma","volume":"4","author":"Chiron D","year":"2014","unstructured":"Chiron D, Di Liberto M, Martin P, Huang X, Sharman J, Blecua P, et al. Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma. Cancer Discov 2014; 4(9): 1022\u20131035.","journal-title":"Cancer Discov"},{"issue":"45","key":"ref10","doi-asserted-by":"crossref","first-page":"73558","DOI":"10.18632\/oncotarget.12434","article-title":"CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma","volume":"7","author":"Mohanty A","year":"2016","unstructured":"Mohanty A, Sandoval N, Das M, Pillai R, Chen L, Chen RW, et al. CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma. Oncotarget 2016; 7(45): 73558\u201373572.","journal-title":"Oncotarget"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"101273","DOI":"10.1016\/j.blre.2025.101273","article-title":"BTK inhibitors resistance in B cell malignancies: Mechanisms and potential therapeutic strategies","volume":"71","author":"Liu X","year":"2025","unstructured":"Liu X, Lin Y, Zhuang Q, Deng H, Liu A, Sun J. BTK inhibitors resistance in B cell malignancies: Mechanisms and potential therapeutic strategies. Blood Rev 2025; 71: 101273.","journal-title":"Blood Rev"},{"issue":"22","key":"ref12","doi-asserted-by":"crossref","first-page":"10867","DOI":"10.1073\/pnas.89.22.10867","article-title":"Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression","volume":"89","author":"Hellmich MR","year":"1992","unstructured":"Hellmich MR, Pant HC, Wada E, Battey JF. Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression. Proc Natl Acad Sci U S A 1992; 89(22): 10867\u201310871.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6496","key":"ref13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/371419a0","article-title":"p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5","volume":"371","author":"Tsai LH","year":"1994","unstructured":"Tsai LH, Delalle I, Caviness VS, Jr., Chae T, Harlow E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 1994; 371(6496): 419\u2013423.","journal-title":"Nature"},{"issue":"17","key":"ref14","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1523\/JNEUROSCI.21-17-06758.2001","article-title":"p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment","volume":"21","author":"Ko J","year":"2001","unstructured":"Ko J, Humbert S, Bronson RT, Takahashi S, Kulkarni AB, Li E, et al. p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci 2001; 21(17): 6758\u20136771.","journal-title":"J Neurosci"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s43556-021-00029-0","article-title":"Post-translational modifications of CDK5 and their biological roles in cancer","volume":"2","author":"Gao GB","year":"2021","unstructured":"Gao GB, Sun Y, Fang RD, Wang Y, Wang Y, He QY. Post-translational modifications of CDK5 and their biological roles in cancer. Mol Biomed 2021; 2(1): 22.","journal-title":"Mol Biomed"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11033-025-10253-4","article-title":"CDK5: Insights into its roles in diseases","volume":"52","author":"Wang J","year":"2025","unstructured":"Wang J, Zhang C, Jiang T, He Y, Wu Y, Zhou D, et al. CDK5: Insights into its roles in diseases. Mol Biol Rep 2025; 52(1): 145.","journal-title":"Mol Biol Rep"},{"issue":"3","key":"ref17","article-title":"Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma","volume":"132","author":"Yi S","year":"2022","unstructured":"Yi S, Yan Y, Jin M, Bhattacharya S, Wang Y, Wu Y, et al. Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma. J Clin Invest 2022; 132(3).","journal-title":"J Clin Invest"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1021\/acs.jmedchem.1c02069","article-title":"Discovery and Optimization of Highly Selective Inhibitors of CDK5","volume":"65","author":"Daniels MH","year":"2022","unstructured":"Daniels MH, Malojcic G, Clugston SL, Williams B, Coeffet-Le Gal M, Pan-Zhou XR, et al. Discovery and Optimization of Highly Selective Inhibitors of CDK5. J Med Chem 2022; 65(4): 3575\u20133596.","journal-title":"J Med Chem"},{"issue":"736","key":"ref19","doi-asserted-by":"crossref","first-page":"eabg5216","DOI":"10.1126\/scisignal.abg5216","article-title":"Kinase-deficient BTK mutants confer ibrutinib resistance through activation of the kinase HCK","volume":"15","author":"Dhami K","year":"2022","unstructured":"Dhami K, Chakraborty A, Gururaja TL, Cheung LW, Sun C, DeAnda F, et al. Kinase-deficient BTK mutants confer ibrutinib resistance through activation of the kinase HCK. Sci Signal 2022; 15(736): eabg5216.","journal-title":"Sci Signal"},{"issue":"17","key":"ref20","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.1073\/pnas.91.17.8152","article-title":"Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction","volume":"91","author":"Cheng G","year":"1994","unstructured":"Cheng G, Ye ZS, Baltimore D. Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction. Proc Natl Acad Sci U S A 1994; 91(17): 8152\u20138155.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/s41375-024-02207-9","article-title":"The dual HCK\/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma","volume":"38","author":"Lantermans HC","year":"2024","unstructured":"Lantermans HC, Ma F, Kuil A, van Kesteren S, Yasinoglu S, Yang G, et al. The dual HCK\/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma. Leukemia 2024; 38(7): 1570\u20131580.","journal-title":"Leukemia"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.3324\/haematol.2017.170571","article-title":"SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia","volume":"102","author":"Paiva C","year":"2017","unstructured":"Paiva C, Rowland TA, Sreekantham B, Godbersen C, Best SR, Kaur P, et al. SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia. Haematologica 2017; 102(11): 1890\u20131900.","journal-title":"Haematologica"},{"issue":"17","key":"ref23","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1158\/1078-0432.CCR-21-0464","article-title":"Pharmacologic Targeting of Mcl-1 Induces Mitochondrial Dysfunction and Apoptosis in B-Cell Lymphoma Cells in a TP53- and BAX-Dependent Manner","volume":"27","author":"Liu T","year":"2021","unstructured":"Liu T, Lam V, Thieme E, Sun D, Wang X, Xu F, et al. Pharmacologic Targeting of Mcl-1 Induces Mitochondrial Dysfunction and Apoptosis in B-Cell Lymphoma Cells in a TP53- and BAX-Dependent Manner. Clin Cancer Res 2021; 27(17): 4910\u20134922.","journal-title":"Clin Cancer Res"},{"issue":"6682","key":"ref24","doi-asserted-by":"crossref","first-page":"eadi5798","DOI":"10.1126\/science.adi5798","article-title":"Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1\/3 degrader NX-2127","volume":"383","author":"Montoya S","year":"2024","unstructured":"Montoya S, Bourcier J, Noviski M, Lu H, Thompson MC, Chirino A, et al. Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1\/3 degrader NX-2127. Science 2024; 383(6682): eadi5798.","journal-title":"Science"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1038\/s41598-017-06012-6","article-title":"CDK5-mediated phosphorylation of XBP1s contributes to its nuclear translocation and activation in MPP(+)-induced Parkinson's disease model","volume":"7","author":"Jiao FJ","year":"2017","unstructured":"Jiao FJ, Wang QZ, Zhang P, Yan JG, Zhang Z, He F, et al. CDK5-mediated phosphorylation of XBP1s contributes to its nuclear translocation and activation in MPP(+)-induced Parkinson's disease model. Sci Rep 2017; 7(1): 5622.","journal-title":"Sci Rep"},{"issue":"15","key":"ref26","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1021\/acschemneuro.3c00341","article-title":"Cdk5-Mediated Brain Unfolded Protein Response Upregulation Associated with Cognitive Impairments in Type 2 Diabetes and Ameliorative Action of NAC","volume":"14","author":"Saha D","year":"2023","unstructured":"Saha D, Paul S, Gaharwar U, Priya A, Neog A, Singh A, et al. Cdk5-Mediated Brain Unfolded Protein Response Upregulation Associated with Cognitive Impairments in Type 2 Diabetes and Ameliorative Action of NAC. ACS Chem Neurosci 2023; 14(15): 2761\u20132774.","journal-title":"ACS Chem Neurosci"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","article-title":"Mechanisms, regulation and functions of the unfolded protein response","volume":"21","author":"Hetz C","year":"2020","unstructured":"Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol 2020; 21(8): 421\u2013438.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"101997","DOI":"10.1016\/j.jbc.2022.101997","article-title":"Phosphorylation at Ser(724) of the ER stress sensor IRE1alpha governs its activation state and limits ER stress-induced hepatosteatosis","volume":"298","author":"Li Y","year":"2022","unstructured":"Li Y, Huang S, Wang J, Dai J, Cai J, Yan S, et al. Phosphorylation at Ser(724) of the ER stress sensor IRE1alpha governs its activation state and limits ER stress-induced hepatosteatosis. J Biol Chem 2022; 298(6): 101997.","journal-title":"J Biol Chem"},{"issue":"8","key":"ref29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nri.2016.62","article-title":"The unfolded protein response in immunity and inflammation","volume":"16","author":"Grootjans J","year":"2016","unstructured":"Grootjans J, Kaser A, Kaufman RJ, Blumberg RS. The unfolded protein response in immunity and inflammation. Nat Rev Immunol 2016; 16(8): 469\u2013484.","journal-title":"Nat Rev Immunol"},{"issue":"21","key":"ref30","doi-asserted-by":"crossref","first-page":"7448","DOI":"10.1128\/MCB.23.21.7448-7459.2003","article-title":"XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response","volume":"23","author":"Lee AH","year":"2003","unstructured":"Lee AH, Iwakoshi NN, Glimcher LH. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol 2003; 23(21): 7448\u20137459.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tem.2016.01.001","article-title":"XBP1: A Pivotal Transcriptional Regulator of Glucose and Lipid Metabolism","volume":"27","author":"Piperi C","year":"2016","unstructured":"Piperi C, Adamopoulos C, Papavassiliou AG. XBP1: A Pivotal Transcriptional Regulator of Glucose and Lipid Metabolism. Trends Endocrinol Metab 2016; 27(3): 119\u2013122.","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"ref32","article-title":"Roles of XBP1s in Transcriptional Regulation of Target Genes","volume":"9","author":"Park SM","year":"2021","unstructured":"Park SM, Kang TI, So JS. Roles of XBP1s in Transcriptional Regulation of Target Genes. Biomedicines 2021; 9(7).","journal-title":"Biomedicines"},{"issue":"34","key":"ref33","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1038\/onc.2011.87","article-title":"Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress","volume":"30","author":"Dong L","year":"2011","unstructured":"Dong L, Jiang CC, Thorne RF, Croft A, Yang F, Liu H, et al. Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress. Oncogene 2011; 30(34): 3716\u20133726.","journal-title":"Oncogene"},{"issue":"16","key":"ref34","doi-asserted-by":"crossref","first-page":"6708","DOI":"10.1158\/0008-5472.CAN-08-0349","article-title":"Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress","volume":"68","author":"Jiang CC","year":"2008","unstructured":"Jiang CC, Lucas K, Avery-Kiejda KA, Wade M, deBock CE, Thorne RF, et al. Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress. Cancer Res 2008; 68(16): 6708\u20136717.","journal-title":"Cancer Res"},{"issue":"10","key":"ref35","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood.2023023659","article-title":"Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib","volume":"144","author":"Woyach JA","year":"2024","unstructured":"Woyach JA, Jones D, Jurczak W, Robak T, Illes A, Kater AP, et al. Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib. Blood 2024; 144(10): 1061\u20131068.","journal-title":"Blood"},{"issue":"24","key":"ref36","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1182\/blood-2016-06-720490","article-title":"Rational targeted therapies to overcome microenvironment-dependent expansion of mantle cell lymphoma","volume":"128","author":"Chiron D","year":"2016","unstructured":"Chiron D, Bellanger C, Papin A, Tessoulin B, Dousset C, Maiga S, et al. Rational targeted therapies to overcome microenvironment-dependent expansion of mantle cell lymphoma. Blood 2016; 128(24): 2808\u20132818.","journal-title":"Blood"},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1182\/blood-2009-12-257485","article-title":"Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma","volume":"116","author":"Leshchenko VV","year":"2010","unstructured":"Leshchenko VV, Kuo PY, Shaknovich R, Yang DT, Gellen T, Petrich A, et al. Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma. Blood 2010; 116(7): 1025\u20131034.","journal-title":"Blood"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12943-023-01895-8","article-title":"CDK5: an oncogene or an anti-oncogene: location location location","volume":"22","author":"Nikhil K","year":"2023","unstructured":"Nikhil K, Shah K. CDK5: an oncogene or an anti-oncogene: location location location. Mol Cancer 2023; 22(1): 186.","journal-title":"Mol Cancer"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"190287","DOI":"10.1098\/rsob.190287","article-title":"A kinase of many talents: non-neuronal functions of CDK5 in development and disease","volume":"10","author":"Sharma S","year":"2020","unstructured":"Sharma S, Sicinski P. A kinase of many talents: non-neuronal functions of CDK5 in development and disease. Open Biol 2020; 10(1): 190287.","journal-title":"Open Biol"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41556-024-01509-5","article-title":"Astrocyte-induced Cdk5 expedites breast cancer brain metastasis by suppressing MHC-I expression to evade immune recognition","volume":"26","author":"Yuzhalin AE","year":"2024","unstructured":"Yuzhalin AE, Lowery FJ, Saito Y, Yuan X, Yao J, Duan Y, et al. Astrocyte-induced Cdk5 expedites breast cancer brain metastasis by suppressing MHC-I expression to evade immune recognition. Nat Cell Biol 2024; 26(10): 1773\u20131789.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0896-6273(00)81200-3","article-title":"Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth","volume":"26","author":"Zukerberg LR","year":"2000","unstructured":"Zukerberg LR, Patrick GN, Nikolic M, Humbert S, Wu CL, Lanier LM, et al. Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron 2000; 26(3): 633\u2013646.","journal-title":"Neuron"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0896-6273(02)00857-7","article-title":"Fyn and Cdk5 mediate semaphorin-3A signaling, which is involved in regulation of dendrite orientation in cerebral cortex","volume":"35","author":"Sasaki Y","year":"2002","unstructured":"Sasaki Y, Cheng C, Uchida Y, Nakajima O, Ohshima T, Yagi T, et al. Fyn and Cdk5 mediate semaphorin-3A signaling, which is involved in regulation of dendrite orientation in cerebral cortex. Neuron 2002; 35(5): 907\u2013920.","journal-title":"Neuron"},{"issue":"21","key":"ref43","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1182\/blood-2017-10-764373","article-title":"Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions","volume":"131","author":"Puente XS","year":"2018","unstructured":"Puente XS, Jares P, Campo E. Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions. Blood 2018; 131(21): 2283\u20132296.","journal-title":"Blood"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061565","article-title":"Management of Drug Resistance in Mantle Cell Lymphoma","volume":"12","author":"Roue G","year":"2020","unstructured":"Roue G, Sola B. Management of Drug Resistance in Mantle Cell Lymphoma. Cancers (Basel) 2020; 12(6).","journal-title":"Cancers (Basel)"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrc1588","article-title":"Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs","volume":"5","author":"Nakanishi C","year":"2005","unstructured":"Nakanishi C, Toi M. Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer 2005; 5(4): 297\u2013309.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"2329130","DOI":"10.1080\/07853890.2024.2329130","article-title":"Research progress on the mechanism of common inflammatory pathways in the pathogenesis and development of lymphoma","volume":"56","author":"Shi A","year":"2024","unstructured":"Shi A, Yun F, Shi L, Liu X, Jia Y. Research progress on the mechanism of common inflammatory pathways in the pathogenesis and development of lymphoma. Ann Med 2024; 56(1): 2329130.","journal-title":"Ann Med"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12967-023-03930-0","article-title":"FYN: emerging biological roles and potential therapeutic targets in cancer","volume":"21","author":"Peng S","year":"2023","unstructured":"Peng S, Fu Y. FYN: emerging biological roles and potential therapeutic targets in cancer. J Transl Med 2023; 21(1): 84.","journal-title":"J Transl Med"},{"issue":"3","key":"ref48","first-page":"893","article-title":"FAM129A promotes invasion and proliferation by activating FAK signaling pathway in non-small cell lung cancer","volume":"12","author":"Zhang N","year":"2019","unstructured":"Zhang N, Zhou XM, Yang FF, Zhang Q, Miao Y, Hou G. FAM129A promotes invasion and proliferation by activating FAK signaling pathway in non-small cell lung cancer. Int J Clin Exp Pathol 2019; 12(3): 893\u2013900.","journal-title":"Int J Clin Exp Pathol"},{"issue":"23","key":"ref49","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151797","article-title":"Tnfrsf4-expressing regulatory T cells promote immune escape of chronic myeloid leukemia stem cells","volume":"6","author":"Hinterbrandner M","year":"2021","unstructured":"Hinterbrandner M, Rubino V, Stoll C, Forster S, Schnuriger N, Radpour R, et al. Tnfrsf4-expressing regulatory T cells promote immune escape of chronic myeloid leukemia stem cells. JCI Insight 2021; 6(23).","journal-title":"JCI Insight"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41392-025-02125-x","article-title":"Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia","volume":"10","author":"Hu X","year":"2025","unstructured":"Hu X, Li L, Nkwocha J, Kmieciak M, Shang S, Cowart LA, et al. Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia. Signal Transduct Target Ther 2025; 10(1): 50.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"ref51","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.leukres.2007.11.032","article-title":"Src family kinases promote AML cell survival through activation of signal transducers and activators of transcription (STAT)","volume":"32","author":"Ozawa Y","year":"2008","unstructured":"Ozawa Y, Williams AH, Estes ML, Matsushita N, Boschelli F, Jove R, et al. Src family kinases promote AML cell survival through activation of signal transducers and activators of transcription (STAT). Leuk Res 2008; 32(6): 893\u2013903.","journal-title":"Leuk Res"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/boc.201800050","article-title":"The role of the unfolded protein response in cancer progression: From oncogenesis to chemoresistance","volume":"111","author":"Madden E","year":"2019","unstructured":"Madden E, Logue SE, Healy SJ, Manie S, Samali A. The role of the unfolded protein response in cancer progression: From oncogenesis to chemoresistance. Biol Cell 2019; 111(1): 1\u201317.","journal-title":"Biol Cell"},{"issue":"11","key":"ref53","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.trecan.2022.06.006","article-title":"Decoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity","volume":"8","author":"Salvagno C","year":"2022","unstructured":"Salvagno C, Mandula JK, Rodriguez PC, Cubillos-Ruiz JR. Decoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity. Trends Cancer 2022; 8(11): 930\u2013943.","journal-title":"Trends Cancer"},{"issue":"6","key":"ref54","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0092-8674(93)90648-A","article-title":"Transcriptional induction of genes encoding endoplasmic reticulum resident proteins requires a transmembrane protein kinase","volume":"73","author":"Cox JS","year":"1993","unstructured":"Cox JS, Shamu CE, Walter P. Transcriptional induction of genes encoding endoplasmic reticulum resident proteins requires a transmembrane protein kinase. Cell 1993; 73(6): 1197\u20131206.","journal-title":"Cell"},{"issue":"9","key":"ref55","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.7150\/jca.29421","article-title":"Unravel the molecular mechanism of XBP1 in regulating the biology of cancer cells","volume":"10","author":"Shi W","year":"2019","unstructured":"Shi W, Chen Z, Li L, Liu H, Zhang R, Cheng Q, et al. Unravel the molecular mechanism of XBP1 in regulating the biology of cancer cells. J Cancer 2019; 10(9): 2035\u20132046.","journal-title":"J Cancer"},{"issue":"5","key":"ref56","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41401-020-00505-3","article-title":"Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphoma","volume":"42","author":"Zhang XT","year":"2021","unstructured":"Zhang XT, Hu XB, Wang HL, Kan WJ, Xu L, Wang ZJ, et al. Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphoma. Acta Pharmacol Sin 2021; 42(5): 814\u2013823.","journal-title":"Acta Pharmacol Sin"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41420-020-0259-2","article-title":"Endoplasmic reticulum stress mediates resistance to BCL-2 inhibitor in uveal melanoma cells","volume":"6","author":"Bellini L","year":"2020","unstructured":"Bellini L, Strub T, Habel N, Pandiani C, Marchetti S, Martel A, et al. Endoplasmic reticulum stress mediates resistance to BCL-2 inhibitor in uveal melanoma cells. Cell Death Discov 2020; 6: 22.","journal-title":"Cell Death Discov"},{"issue":"17","key":"ref58","doi-asserted-by":"crossref","first-page":"9946","DOI":"10.1073\/pnas.1334037100","article-title":"Proteasome inhibitors disrupt the unfolded protein response in myeloma cells","volume":"100","author":"Lee AH","year":"2003","unstructured":"Lee AH, Iwakoshi NN, Anderson KC, Glimcher LH. Proteasome inhibitors disrupt the unfolded protein response in myeloma cells. Proc Natl Acad Sci U S A 2003; 100(17): 9946\u20139951.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref59","doi-asserted-by":"crossref","DOI":"10.3390\/cells11040632","article-title":"Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma","volume":"11","author":"Khaled J","year":"2022","unstructured":"Khaled J, Kopsida M, Lennernas H, Heindryckx F. Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma. Cells 2022; 11(4).","journal-title":"Cells"},{"issue":"4","key":"ref60","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/mol.119.116855","article-title":"CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax","volume":"96","author":"Kour S","year":"2019","unstructured":"Kour S, Rana S, Contreras JI, King HM, Robb CM, Sonawane YA, et al. CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax. Mol Pharmacol 2019; 96(4): 419\u2013429.","journal-title":"Mol Pharmacol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9500406\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9500406\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T23:50:19Z","timestamp":1780876219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9500406\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":60,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9500406\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,5,8]]},"subtype":"preprint"}}